Kira Pharmaceuticals

Kira Pharmaceuticals is a global biotechnology company at the forefront of pioneering innovative solutions for complement diseases. Driven by its proprietary LOGIC platform, Kira Pharmaceuticals has cultivated a diverse pipeline of novel complement assets, targeting critical points within the complement cascade. These advancements hold significant promise for developing first-in-class and best-in-class therapies.

Headquartered in Cambridge, Massachusetts, with additional offices in Suzhou and Shanghai, China, and Australia, Kira Pharmaceuticals brings together a team of seasoned experts in complement biology, drug development, and protein engineering. This team is dedicated to addressing the intricate challenges in the complement space, striving to improve patient outcomes and transform lives.

Kira Pharmaceuticals is committed to advancing research and development in the field of biotechnology. With its strategic focus and experienced team, Kira Pharmaceuticals is poised to make a substantial impact on global healthcare. For further information, the company can be reached at its primary address in Cambridge, MA, US. We invite the management of Kira Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform.